The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in infla
- PDF / 264,059 Bytes
- 8 Pages / 547.087 x 737.008 pts Page_size
- 44 Downloads / 159 Views
(0123456789().,-volV) ( 01234567 89().,-volV)
ORIGINAL PAPER
The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases Maria Vadala` . Chiara Davı` . Giuseppe Ingrassia Strano . Enrica Giuffrida . Barbara Scrivo . Nicasio Ventura . Massimo Castellucci . Salvatore Cillino . Calogero Camma` . Maria Cappello
Received: 23 February 2020 / Accepted: 19 May 2020 Springer Nature B.V. 2020
Abstract Purpose To assess the usefulness of a dedicated questionnaire for patients with inflammatory bowel diseases (IBD) treated with biological drugs for the detection of ocular extraintestinal manifestations (EIMs). IBD can cause extraintestinal symptoms including ocular complaints which are frequently ignored and may be associated with significant morbidity, including blindness. Methods We developed a questionnaire, named Ocular Manifestations in IBD Screening (OMIS) questionnaire, after agreement between gastroenterologists and ophthalmologists. The questionnaire was administered by a non-ophthalmologist physician to 96 IBD patients treated with biological drugs. Results 35 patients (36.5%) were selected for the ophthalmologic examination on the basis of a positive screening test. Ocular EIMs were detected in 29 of 35 patients (83%).
M. Vadala` (&) C. Davı` N. Ventura M. Castellucci S. Cillino Biomedicine, Neuroscience and Advance Diagnostic (BIND) Department, Ophthalmology Institute, University of Palermo, Via Liborio Giuffre` 13, 90127 Palermo, Italy e-mail: [email protected] G. Ingrassia Strano E. Giuffrida B. Scrivo C. Camma` M. Cappello Gastroenterology and Hepatology Section, ProMiSe Department, University of Palermo, Palermo, Italy
Conclusion A specific questionnaire can be useful for non-ophthalmologist physicians in a real world setting in order to select patients to be addressed to an ophthalmological visit, creating an integrated multidisciplinary clinical team, to improve management of IBD in order to prevent disability and guarantee quality of life. Keywords Biologic drugs Inflammatory bowel disease Ocular extraintestinal manifestation Questionnaire
Introduction Inflammatory bowel diseases (IBD), also named Crohn’s disease (CD) and ulcerative colitis (UC), are chronic conditions of the bowel of unknown etiology. IBD can be considered as systemic disorders since, beside intestinal symptoms and complications, they can cause extraintestinal symptoms (extraintestinal manifestations, EIMs) which can potentially affect any organ and impact on the functional status and quality of life of the patient [1]. The prevalence of EIMs in published studies ranges widely from 6 to 47% [2], which is due to different settings (hospital versus population studies, tertiary centers versus primary care) and methodological design (retrospective versus prospective). EIMs can be present at diagnosis, or even precede it, or appear during the
123
Int Ophthalmol
course of IBD. The presence of one EIM increases the probability
Data Loading...
